A ssDNA aptamer that blocks the function of the anti-FLAG M2 antibody

Amanda S. Lakamp, Michel M Ouellette

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Using SELEX (systematic evolution of ligands by exponential enrichment), we serendipitously discovered a ssDNA aptamer that binds selectively to the anti-FLAG M2 antibody. The aptamer consisted of two motifs (CCTTA and TGTCTWCC) separated by 2-3 bases, and the elimination of one or the other motif abrogated binding. The DNA aptamer and FLAG peptide competed for binding to the antigen-binding pocket of the M2 antibody. In addition, the aptamer eluted FLAG-tagged proteins from the antibody, suggesting a commercial application in protein purification. These findings demonstrate the feasibility of using SELEX to develop ssDNA aptamers that block the function of a specific antibody, a capability that could lead to the development of novel therapeutic modalities for patients with systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases.

Original languageEnglish (US)
Article number720798
JournalJournal of Nucleic Acids
Volume2011
DOIs
StatePublished - Dec 1 2011

Fingerprint

SELEX Aptamer Technique
Antibodies
Nucleotide Aptamers
Ligands
Systemic Lupus Erythematosus
Autoimmune Diseases
Purification
Rheumatoid Arthritis
Proteins
Antigens
Therapeutics

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

A ssDNA aptamer that blocks the function of the anti-FLAG M2 antibody. / Lakamp, Amanda S.; Ouellette, Michel M.

In: Journal of Nucleic Acids, Vol. 2011, 720798, 01.12.2011.

Research output: Contribution to journalArticle

@article{1e531dbddfc04a48821c6245f3c3760b,
title = "A ssDNA aptamer that blocks the function of the anti-FLAG M2 antibody",
abstract = "Using SELEX (systematic evolution of ligands by exponential enrichment), we serendipitously discovered a ssDNA aptamer that binds selectively to the anti-FLAG M2 antibody. The aptamer consisted of two motifs (CCTTA and TGTCTWCC) separated by 2-3 bases, and the elimination of one or the other motif abrogated binding. The DNA aptamer and FLAG peptide competed for binding to the antigen-binding pocket of the M2 antibody. In addition, the aptamer eluted FLAG-tagged proteins from the antibody, suggesting a commercial application in protein purification. These findings demonstrate the feasibility of using SELEX to develop ssDNA aptamers that block the function of a specific antibody, a capability that could lead to the development of novel therapeutic modalities for patients with systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases.",
author = "Lakamp, {Amanda S.} and Ouellette, {Michel M}",
year = "2011",
month = "12",
day = "1",
doi = "10.4061/2011/720798",
language = "English (US)",
volume = "2011",
journal = "Journal of Nucleic Acids",
issn = "2090-0201",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - A ssDNA aptamer that blocks the function of the anti-FLAG M2 antibody

AU - Lakamp, Amanda S.

AU - Ouellette, Michel M

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Using SELEX (systematic evolution of ligands by exponential enrichment), we serendipitously discovered a ssDNA aptamer that binds selectively to the anti-FLAG M2 antibody. The aptamer consisted of two motifs (CCTTA and TGTCTWCC) separated by 2-3 bases, and the elimination of one or the other motif abrogated binding. The DNA aptamer and FLAG peptide competed for binding to the antigen-binding pocket of the M2 antibody. In addition, the aptamer eluted FLAG-tagged proteins from the antibody, suggesting a commercial application in protein purification. These findings demonstrate the feasibility of using SELEX to develop ssDNA aptamers that block the function of a specific antibody, a capability that could lead to the development of novel therapeutic modalities for patients with systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases.

AB - Using SELEX (systematic evolution of ligands by exponential enrichment), we serendipitously discovered a ssDNA aptamer that binds selectively to the anti-FLAG M2 antibody. The aptamer consisted of two motifs (CCTTA and TGTCTWCC) separated by 2-3 bases, and the elimination of one or the other motif abrogated binding. The DNA aptamer and FLAG peptide competed for binding to the antigen-binding pocket of the M2 antibody. In addition, the aptamer eluted FLAG-tagged proteins from the antibody, suggesting a commercial application in protein purification. These findings demonstrate the feasibility of using SELEX to develop ssDNA aptamers that block the function of a specific antibody, a capability that could lead to the development of novel therapeutic modalities for patients with systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases.

UR - http://www.scopus.com/inward/record.url?scp=84867498328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867498328&partnerID=8YFLogxK

U2 - 10.4061/2011/720798

DO - 10.4061/2011/720798

M3 - Article

C2 - 22013507

AN - SCOPUS:84867498328

VL - 2011

JO - Journal of Nucleic Acids

JF - Journal of Nucleic Acids

SN - 2090-0201

M1 - 720798

ER -